Anders Svenningsson
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis. (NCT02746744) | Anders Svenningsson | 2016-05-01 |
| Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis (NCT01719159) | Anders Svenningsson | 2009-11-01 |
Track Anders Svenningsson automatically
Every clearance here is in the API, with alerts when new ones post.